000 | 01666 a2200481 4500 | ||
---|---|---|---|
005 | 20250517040427.0 | ||
264 | 0 | _c20160406 | |
008 | 201604s 0 0 spa d | ||
022 | _a1576-6578 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aToribio-Diaz, M Elena | |
245 | 0 | 0 |
_a[Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia]. _h[electronic resource] |
260 |
_bRevista de neurologia _cJul 2015 |
||
300 |
_a14-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
650 | 0 | 4 | _aAtrophy |
650 | 0 | 4 | _aAttention |
650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
650 | 0 | 4 |
_aBrain _xpathology |
650 | 0 | 4 |
_aCognitive Dysfunction _xcerebrospinal fluid |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 |
_aDementia _xcerebrospinal fluid |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aExecutive Function |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLanguage Disorders _xepidemiology |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 |
_aMemory Disorders _xepidemiology |
650 | 0 | 4 | _aNeuroimaging |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 |
_aParkinson Disease _xcerebrospinal fluid |
650 | 0 | 4 |
_aPeptide Fragments _xcerebrospinal fluid |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSymptom Assessment |
650 | 0 | 4 |
_aalpha-Synuclein _xcerebrospinal fluid |
700 | 1 | _aCarod-Artal, Francisco J | |
773 | 0 |
_tRevista de neurologia _gvol. 61 _gno. 1 _gp. 14-24 |
|
999 |
_c25014755 _d25014755 |